Displaying 61 - 72 of 496
Immune-Mediated and Cholestatic Diseases

Potential for IBAT Inhitors in PSC: Will the Paediatric Experience Translate to Adults?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

IBAT Inhibitor Mechanism of Action and Experience in Paediactrics

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Role and Impact of Bile Acids in Cholestatic Liver Disease

Webcasts
View
Cirrhosis & Complications

Conclusions and future perspectives

Webcasts
View
Cirrhosis & Complications

How long, how much and to whom? Real world data from more than 5 years practice

Webcasts
View
Cirrhosis & Complications

From decompensated cirrhosis to ACLF: long term albumin among the available and novel treatments

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Q&A and Close

Webcasts
View
Cirrhosis & Complications

Q&A

Webcasts
View
General Hepatology

A real-life example of multidisciplinary care: Patient with AATD and metabolic liver disease

Webcasts
View
General Hepatology

Takeda: A tale of two specialties in AATD: An interactive discussion of case studies (Complete Session)

Webcasts
View
General Hepatology

Welcome and introduction

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Ipsen: Shining a light on unexplained cholestasis (Complete Session)

Webcasts
View
Displaying 61 - 72 of 496